a) ECM components and collagen structure change with tumor progression, which influences cancer cell proliferation and metastasis. b) SHG visual representation of collagen patterns... by Zoë Dinkel (21402766)

Long-term Continuous CORT treatment decreases Flk1 protein levels <i>in vitro</i> and <i>in vivo</i>. by Kristy R. Howell (350779)

<i>Cdkl5</i> -/Y mice show an increased freezing time and a decreased distance traveled during the pretone period in the altered context. by Kosuke Okuda (5150393)

“…<i>Cdkl5</i> -/Y mice show a significantly decreased distance traveled in response to the first footshock (p = 0.0158) compared with control mice. …”

Decreased cholesterol accumulation in the liver of <i>LDLR</i>^−/−/<i>MPO</i>^−/−tp mice. by Sander S. Rensen (292951)

Establishing environmental soil phosphorus thresholds to decrease the risk of losses to water in soils from Rio Grande do Sul, Brazil by Luciano Colpo Gatiboni (4619761)

a-c: Proximal tibia (PT) EPO receptor (EPO-R) decreases in uremic rats, as shown by Western blot (Fig. 5a) and immunohistochemistry (Fig. 5b). by Daniel Landau (440830)

“…Animals received a single bolus of IV rhEPO (25 U/kg) or saline, 5 minutes prior to sacrifice. …”

Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response. by Marc Swidergall (185453)

Subnetwork of core DE genes with ≥5.0 degree and a fold change of ≥2.0 (50 nodes and 97 edges). by Reena Arora (1464781)

Concentration-dependent i⁶A37 modification of cy-tRNA^TrpCCA. by Abdul Khalique (5029442)

Identification of small molecules that inhibit viral M mRNA nuclear export and/or decrease viral M mRNA levels. by Matthew Esparza (8661219)

“…<p>(<b>A</b>) Representative images showing uninfected cells; cells infected with A/WSN/33 and pretreated with 0.5% DMSO (control), which show viral M mRNA exported into the cytoplasm, in red; and cells infected with A/WSN/33 pre-treated with 2.5 μM of the transcription inhibitor DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole). …”

Sample cases of each type of visual field defect. by Kyoung Min Lee (677987)

Decreased dCAP-D3 levels result in spreading of repressive histone marks and an opening of the chromatin at a dCAP-D3 regulated gene cluster containing a retrotransposon. by Andrew T. Schuster (478446)

“…(B) qRT-PCR for transcript levels of genes surrounding <i>mdg1-1403</i> (as depicted in diagram in A) indicates that compared to control dsRNA treated cells, transcription is decreased in dCAP-D3 dsRNA treated cells prior to retrotransposon mobilization (day 4) and increases to almost normal levels on the day of retrotransposon mobilization (day 5). …”

Decrease of Population Divergence in Eurasian Perch (<i>Perca fluviatilis</i>) in Browning Waters: Role of Fatty Acids and Foraging Efficiency by Kristin Scharnweber (2742514)

“…We expected a decrease in the prevalence of PUFAs, which are important for perch growth and divergence with increasing DOC concentrations, due to the restructuring effects of DOC on aquatic food webs. …”

Maintenance of a single Zeb2 wt allele rescues PB cytopenia and severe differentiation defects in Zeb1/2 DKO HSPCs. by Jueqiong Wang (11467505)

Treatment of infected neonatal mice with prednisolone decreases the expression of proinflammatory cytokines and interferon stimulated genes in the brain of MCMV infected mice. by Kate Kosmac (386527)

Decrease in gastrin-, histidine decarboxylase-, and somatostatin mRNA due to the <i>H. pylori</i> B128 WT-infection. by Tobias Wiedemann (266622)

Decreased expression of the γ-glutamylcysteine ligase and increased hepatic oxidant generation and protein oxidative damage at Day+4 in Allo BMT. by Jung H. Suh (523844)

FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway. by Ramazan Kurt (449801)

METH decreased basal pERK1/2 levels and potentiated ERK1/2 phosphorylation induced by 6-OHDA. by Amina El Ayadi (341955)

“…METH decreased activation of ERK 1/2 in a concentration-dependent manner (0, 0.5, and 1 mM at the 24 hr time point) and enhanced the activation of ERK1/2 after 6-OHDA exposure. …”

Α-difluoromethylornithine (DFMO) treatment decreases meprin α expression in MDA-MB-435 cells, but not in MDA-MB-231 cells by Monica M Richert (63671)

“…<p><b>Copyright information:</b></p><p>Taken from "Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment"</p><p>Breast Cancer Research 2005;7(5):R819-R827.…”